The first real shift in how Americans eat in 80 years. 

GLP-1 medications are not a diet trend. They are a biological restructuring of appetite, eating behavior, and the consumer’s relationship with food. The implications for food brands, restaurants, and grocery are enormous. Most companies are only beginning to understand what they’re facing.

35% of food & beverage sales projected to be driven by GLP-1 users by 2030 Circana

2× GLP-1 adoption among U.S. adults has doubled in the past 18 months Upland

1 in 8 U.S. adults report having tried a GLP-1 medication Upland National Study

The conversation is focused on the wrong question. 

Most of the current discussion about GLP-1 is happening at the category level. Snacks will decline, fast food will suffer and protein will grow. That framing is too simple. It misses what is actually being disrupted.

This is not a story about what people eat. It is a story about how often they eat, how they think about food, and how much mental and emotional energy food occupies in their lives. That shift touches every part of the food system and it is already underway. 

“GLP-1s have the makings of being the first thing to decrease food consumption in the U.S. since the end of World War II, when industrial food production reshaped how Americans eat.” 

For 20 years, food behavior has changed slowly. Trends come and go. The structure of how people eat stays relatively the same. GLP-1 is different. It works at a biological level, reducing appetite in ways that ripple across purchase frequency, basket composition, occasion structure and brand loyalty. The companies paying attention now will have a significant advantage over those waiting for the data to catch up. 

We studied it properly. Here’s what we found. 

Upland launched the first national research initiative exploring the consumer experience of GLP-1, including people currently using the medications and those who have stopped or refused to use them altogether.

What we found is far more complex and more interesting than the headlines suggest. 

The GLP-1 story is still being written. 

When consumers experience food differently, entire industries eventually follow. The question for leadership teams is not whether this will affect their business. It’s whether they’ll see it coming.